-
International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-192021 European Journal of Cancer article Medicine Cutaneous lymphoproliferative disorders research Open access
Larisa J. Geskin, Tiffany J. Garcia-Saleem, Oleg E. Akilov, Paula Andrea ENZ, Emmanuella Guenova, Pablo Luis Ortiz-Romero, +7 more
0citations -
Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients2022 European Journal of Cancer article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Emma C. Hulshof, Mirjam de With, Geert‐Jan Creemers, Henk‐Jan Guchelaar, Ron H.J. Mathijssen, Hans A. J. Gelderblom, +1 more
0citations -
Early detection of breast cancer in high-risk women based on longitudinal changes in serum-based proteins: the TESTBREAST study2022 European Journal of Cancer article Chemistry Advanced Proteomics Techniques and Applications Open access
Sophie C. Hagenaars, B. Ravesteijn, L. Dekker, L. Verhoeff, J. Aalberts, Elma Meershoek‐Klein Kranenbarg, +12 more
0citations -
Effect of breast cancer molecular subtype on axillary treatment strategies based on baseline 18F-FDG PET/CT findings2024 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
C. de Mooij, Janine M. Simons, Cristina Mitea, PJ van Diest, Patricia Joan Nelemans, C. Van der Pol, +4 more
0citations -
Quality assurance of radiation therapy among patients in the BOOG 2013-08 trial2024 European Journal of Cancer article Physics and Astronomy Advanced Radiotherapy Techniques Open access
Veerle Marieke Wintraecken, Liesbeth Jorinne Boersma, Lori van Roozendaal, J. de Vries, Sander M. J. van Kuijk, Marissa L. G. Vane, +12 more
0citations -
The impact of personality traits on health-related quality of life in cT1-2N0 breast cancer patients treated with breast-conserving therapy: Three years patient-reported outcomes of the BOOG 2013-08 randomized controlled trial
Veerle Marieke Wintraecken, Lori van Roozendaal, Jolanda De Vries, Sander M. J. van Kuijk, Helena Sackey, Marissa L. G. Vane, +13 more
0citations -
The INFLUENCE 3.0 model: time-dependent risks of locoregional recurrence and contralateral breast cancer, now also including patients treated with neoadjuvant systemic therapy2024 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Marissa Corine van Maaren, Tom A. Hueting, D. van Uden, Marjan van Hezewijk, Linda de Munck, A. Zeillemaker, +4 more
0citations -
Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study2024 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Annemiek van Ommen‐Nijhof, Tessa Gerjanne Steenbruggen, Terry G. Wiersma, S. Balduzzi, Antonios Daletzakis, M. Holtkamp, +10 more
0citations -
Response to Letter Re: Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels2025 European Journal of Cancer article Medicine Colorectal Cancer Treatments and Studies Open access
Niels Heersche, Ron H.J. Mathijssen, Annemieke Cats, Henk‐Jan Guchelaar, Jonathan Emanuel Knikman
0citations -
Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/nivolumab in poor prognostic advanced melanoma2025 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Alfons J.M. van den Eertwegh, John B.A.G. Haanen, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, C.U. Blank, Willeke A.M. Blokx, +12 more
0citations -
Factors associated with pathological confirmation of synchronous and metachronous metastasis in breast cancer patients2026 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Sabine Siesling, L. Woudstra, L. de Munck, Ellis Slotman, C. Schröder, C. van Deurzen, +3 more
0citations -
Development of a multimodal prediction model for axillary pathologic complete response in clinically node-positive breast cancer treated with neoadjuvant chemo-immunotherapy2026 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Melissa Lenaerts, Florien J G van Amstel, Sander M. J. van Kuijk, Carmen C. van der Pol, L.B. Koppert, Ernest J. T. Luiten, +3 more
0citations